Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
10.96
-0.26 (-2.27%)
May 20, 2024, 10:10 AM EDT - Market open
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $52.05 million as of May 20, 2024. Its market cap has decreased by -50.99% in one year.
Market Cap
52.05M
Enterprise Value
26.77M
1-Year Change
-50.99%
Ranking
Category
Stock Price
$10.96
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has decreased from $203.10M to $52.05M, a decrease of -74.37%. That is a compound annual growth rate of -13.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 51.10M | -6.58% |
May 16, 2024 | 54.70M | -5.69% |
May 15, 2024 | 58.00M | -2.85% |
May 14, 2024 | 59.70M | 3.11% |
May 13, 2024 | 57.90M | 4.32% |
May 10, 2024 | 55.50M | -3.48% |
May 9, 2024 | 57.50M | -3.36% |
May 8, 2024 | 59.50M | -2.94% |
May 7, 2024 | 61.30M | -1.29% |
May 6, 2024 | 62.10M | 8.76% |
May 3, 2024 | 57.10M | -1.21% |
May 2, 2024 | 57.80M | 7.24% |
May 1, 2024 | 53.90M | -1.28% |
Apr 30, 2024 | 54.60M | -2.85% |
Apr 29, 2024 | 56.20M | -2.43% |
Apr 26, 2024 | 57.60M | -2.87% |
Apr 25, 2024 | 59.30M | 5.70% |
Apr 24, 2024 | 56.10M | 19.87% |
Apr 23, 2024 | 46.80M | -0.21% |
Apr 22, 2024 | 46.90M | -23.86% |
Apr 19, 2024 | 61.60M | -5.67% |
Apr 18, 2024 | 65.30M | - |
Apr 17, 2024 | 65.30M | -1.06% |
Apr 16, 2024 | 66.00M | -11.53% |
Apr 15, 2024 | 74.60M | 1.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kezar Life Sciences | 55.86M |
HeartBeam | 54.63M |
Modular Medical | 54.54M |
Milestone Scientific | 54.42M |
Rockwell Medical | 54.27M |
BioLineRx | 52.97M |
Cytosorbents | 52.41M |
Aligos Therapeutics | 51.63M |